Instead, the firm requested something far more revealing: “The 90-day decisional letter following the April 2026 FDA inspection.” Evercore’s FDA FOIA request is more likely related to its equity research, advisory work, or other client services than to a disclosed position in its wealth-management portfolio. Viewed together, the recent FOIA requests suggest investors are no longer trying merely to understand what inspectors found at Novo’s Bloomington facility. FOIAengine is the only source for the most comprehensive, fully searchable archive of FOIA requests across over 40 federal departments and agencies. PoliScio now offers everyone free daily FOIAengine Email Alerts when a new FOIA request matches one of your personal keywords.